US Bancorp’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.2K Buy
3,116
+1,055
+51% +$9.9K ﹤0.01% 3020
2025
Q1
$14.7K Buy
2,061
+416
+25% +$2.96K ﹤0.01% 3297
2024
Q4
$19.2K Buy
1,645
+890
+118% +$10.4K ﹤0.01% 3174
2024
Q3
$15.5K Sell
755
-140
-16% -$2.88K ﹤0.01% 3213
2024
Q2
$20K Sell
895
-6,371
-88% -$143K ﹤0.01% 3058
2024
Q1
$200K Sell
7,266
-1,610
-18% -$44.3K ﹤0.01% 2010
2023
Q4
$271K Buy
8,876
+2,189
+33% +$66.7K ﹤0.01% 1848
2023
Q3
$211K Sell
6,687
-212
-3% -$6.7K ﹤0.01% 1799
2023
Q2
$281K Sell
6,899
-151
-2% -$6.16K ﹤0.01% 1687
2023
Q1
$263K Buy
7,050
+585
+9% +$21.8K ﹤0.01% 1735
2022
Q4
$226K Sell
6,465
-5,575
-46% -$195K ﹤0.01% 1800
2022
Q3
$673K Buy
12,040
+3,345
+38% +$187K ﹤0.01% 1248
2022
Q2
$449K Sell
8,695
-6,508
-43% -$336K ﹤0.01% 1505
2022
Q1
$1.1M Buy
15,203
+558
+4% +$40.5K ﹤0.01% 1137
2021
Q4
$1.73M Buy
14,645
+1,800
+14% +$213K ﹤0.01% 964
2021
Q3
$1.72M Buy
12,845
+1,444
+13% +$194K ﹤0.01% 932
2021
Q2
$1.85M Buy
11,401
+5,375
+89% +$870K ﹤0.01% 915
2021
Q1
$484K Buy
6,026
+5,351
+793% +$430K ﹤0.01% 1520
2020
Q4
$37K Sell
675
-2,300
-77% -$126K ﹤0.01% 2624
2020
Q3
$59K Sell
2,975
-2,500
-46% -$49.6K ﹤0.01% 2308
2020
Q2
$115K Buy
5,475
+2,000
+58% +$42K ﹤0.01% 2015
2020
Q1
$42K Buy
3,475
+3,300
+1,886% +$39.9K ﹤0.01% 2377
2019
Q4
$3K Hold
175
﹤0.01% 3350
2019
Q3
$2K Hold
175
﹤0.01% 3429
2019
Q2
$3K Hold
175
﹤0.01% 3389
2019
Q1
$3K Hold
175
﹤0.01% 3355
2018
Q4
$2K Hold
175
﹤0.01% 3418
2018
Q3
$5K Buy
+175
New +$5K ﹤0.01% 3320